Biotech News

Viðskipti stjórnenda og tengdra aðila

Alvotech (ALVO)AlvotechFinancing

Accessibility: Skip TopNav

Automobiles and Parts News

Food & Beverage News

Home Goods & Construction News

Leisure Goods News

Media & Entertainment News

Personal Care News

Retail News

Travel and Leisure News

Alternative Energy News

Oil Gas and Coal News

Chemicals News

Banking News

Closed-End Investments News

Finance and Credit Services News

Investment Banking and Brokerage Services News

Insurance News

Real Estate & REITs News

Healthcare Providers News

Medical Equipment News

Medical Supplies and Services News

Biotechnology News

Pharmaceuticals News

Cannabis Producers News

Aerospace and Defense News

Construction and Materials News

Utilities News

Industrials News

Metals & Mining News

Software News

IT Services News

Semiconductors News

Electronic Components & Equipment News

Computer Hardware News

Telecom Equipment News

Telecom Services News

June 10, 2026 16:30 ET | Source: Alvotech

Í viðhengi er tilkynning um viðskipti stjórnenda og tengdra aðila sem lögð var inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF), varðandi afhendingu hlutabréfa til stjórnarmanns Alvotech í samræmi við gerðan samning um þóknun fyrir stjórnarsetu.

Viðhengi

Managers Transactions - CSSF Form - Hjorleifur Palsson 2026-06-08

Attachments

Managers Transactions - CSSF Form - Hjorleifur Palsson 2026-06-08...

Recommended Reading

July 03, 2026 16:01 ET | Source: Alvotech

Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging...

Read More

July 01, 2026 04:00 ET | Source: Alvotech

$75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset ManagementFollows recent $165m equity raise strengthening cash positionIncluding equity financing and...

Read More

Related news

Alvotech

Alvotech is a biosimilars company developing and manufacturing lower-cost alternatives to complex biologic medicines.

Recent company news

Stock data

Close
3.08 USD
Market cap
936.14M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States